Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication in Zhongshan Hospital
NCT05061732Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Sep 2021
- Primary completion
- Jun 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole, amoxicillin, bismuth subcitrate, metronidazole, clarithromycin in Helicobacter pylori infection, sponsored by Zhongshan Hospital, Fudan University. Started Sep 2021; status: recruiting.
02
Drugs
rabeprazoleamoxicillinbismuth subcitratemetronidazoleclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05061732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05061732.